Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

Chemo before radiotherapy improves efficacy of treatment in testicular cancer patients with low side effects

Giving men with testicular cancer a single dose of chemotherapy alongside radiotherapy could improve the effectiveness of treatment and reduce the risk of long-term side-effects, a new study reports.

17 Aug 2013

Oraya Therapy Stereotactic Radiotherapy for treatment of wet AMDs now available at Optegra

Oraya Therapeutics, Inc. announced today that the Oraya Therapy Stereotactic Radiotherapy for the treatment of wet age-related macular degeneration (AMD) is now available at Optegra Manchester Eye Hospital, becoming the second facility in the UK to provide the therapy.

14 Aug 2013

RaySearch Laboratories announces first patient treated with RayStation

RaySearch Laboratories AB announces that the first patient in Australasia has been treated with a treatment plan created with RaySearch's treatment planning system RayStation®. The treatment was carried out at Auckland Radiation Oncology in Auckland, New Zealand.

From Elekta 13 Aug 2013

Perrigo Company and Teva Pharmaceutical launch generic equivalent to temozolomide

Teva Pharmaceutical Industries Ltd. and Perrigo Company today announced the launch of the generic equivalent to Temodar (temozolomide).

13 Aug 2013

Carbon ion radiotherapy controls cancer growth, prolongs survival in patients with spinal tumors

A new analysis has found that a type of radiation therapy called carbon ion radiotherapy can control cancer growth and prolong survival in patients with spinal tumors. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that the treatment is a promising alternative for patients whose spinal tumors cannot be surgically removed.

12 Aug 2013

Toshiba receives order from NIRS for carbon ion radiotherapy system

Toshiba Corporation today announced that it has received an order from Japan's National Institute of Radiological Sciences (NIRS) for the world's first rotating gantry irradiation system with superconducting magnets for a carbon ion radiotherapy system. The system will be installed in a new radiotherapy room that NIRS is constructing at its facility in Chiba, east of Tokyo, in March 2015.

2 Aug 2013

International meeting to focus on carbon ion radiotherapy for cancer patients

Cancer experts from around the world are converging in Denver on Thursday and Friday to analyze the success of cutting-edge radiation therapies, and to determine how one promising treatment option could be delivered for the first time to cancer patients in the United States.

2 Aug 2013

Cedars-Sinai physicist receives William D. Coolidge Award for pioneering work in radiation oncology

Benedick Fraass, PhD, FAAPM, FASTRO, FACR, received the highest honor from the American Association of Physicists in Medicine — the William D. Coolidge Award — for his distinguished career achievements in medical physics, including his pioneering work in radiation oncology.

1 Aug 2013

Child cancer survival: an interview with Prof Kathy Pritchard-Jones, University College London

Back in the early 1960s, just before chemotherapy really started to be used, only about 30% of children survived cancer. That was mainly because they had cancers that were amenable to surgery.

24 Jul 2013

Female cancer patients unhappy with the way doctors discussed about fertility preservation options

Young female cancer patients are unhappy about the way fertility preservation options are discussed with them by doctors before starting cancer treatment, according to a new study by researchers from the University of Sheffield and The Children's Hospital, Sheffield.

23 Jul 2013

Elekta gets CE Mark approval for Clarity 4D Monitoring system

Elekta has received CE marking for its Clarity 4D Monitoring system permitting European clinics to implement this new way of reducing the uncertainty caused by prostate motion during radiation treatment. Physicians will be able to monitor the motion of the prostate with sub millimeter accuracy during the delivery of therapeutic radiation beams.

From Elekta 19 Jul 2013

Phase 2 EORTC trial shows moderate dose radiotherapy is effective in desmoid-type fibromatosis patients

A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.

19 Jul 2013

Cancer patients who receive chest radiation should screen for heart disease every 5-10 years

Cancer patients who receive chest radiation should be screened for heart disease every 5-10 years, according to the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC) and the American Society of Echocardiography (ASE).

17 Jul 2013

Cancer patients who receive chest radiation should be screened for heart disease every 5-10 years

16 Jul 2013

Scientists discover novel method to kill cancer cells

A University of Southampton Professor, in collaboration with colleagues at the BC Cancer Agency Research Centre, have discovered a novel way of killing cancer cells. The research, recently published in the journal Cell, has found a new potential treatment for cancer, which leaves the body's healthy cells undamaged, unlike traditional therapies such as radiotherapy

15 Jul 2013

Researchers find new potential treatment for cancer

12 Jul 2013

Global recruitment drive to bring best cancer experts to Manchester now underway

A global recruitment drive to bring 20 of the world's best cancer experts and their teams to Manchester, in the United Kingdom, is now underway.

From The University of Manchester 12 Jul 2013

SBRT treatment safe and effective for stage I NSCLC, study finds

Stereotactic body radiotherapy is considered the treatment of choice for early-stage non-small-cell lung cancer if patients are inoperable because of additional medical conditions.

2 Jul 2013

Researchers to use $6.3M grant to develop novel therapeutic approaches for pediatric sarcomas

Researchers at Nationwide Children's Hospital will use a $6.3 million grant to further their study of pediatric sarcomas, a rare form of the disease that affects bone or soft tissue and accounts for 11 percent of all childhood cancers.

27 Jun 2013

Pretreatment PET staging of LS-SCLC associated with improved survival

Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC). Approximately 39 percent of patients with SCLC are diagnosed with limited-stage disease, meaning the cancer is only present in one lung, but may have spread to lymph nodes or tissue between the lungs.

26 Jun 2013